Strikingly, suppression of EGF/Spitz by RNAi expression in RasV12 clones strongly reduces invasive tumour frequency (Fig. 7c), showing that expression of this ligand sustains RasV12-driven basal extrusion in the accessory gland. The gene discussed is EGF; the disease is neoplasm.